Freya Biosciences advances microbial treatment for IVF implantation failure

Freya Biosciences is moving a microbial immunotherapy for IVF implantation failure into mid-stage trials after promising results in healthy volunteers. The Phase 2 study is testing Freya’s candidate, called FB301, in women with vaginal dysbiosis ...